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Abstract: Self-assembly of proteins to β-sheet rich amyloid fibrils is commonly observed in various
neurodegenerative diseases. However, amyloid also occurs in the extracellular matrix of bacterial
biofilm, which protects bacteria from environmental stress and antibiotics. Many Pseudomonas strains
produce functional amyloid where the main component is the highly fibrillation-prone protein FapC.
FapC fibrillation may be inhibited by small molecules such as plant polyphenols, which are already
known to inhibit formation of pathogenic amyloid, but the mechanism and biological impact of
inhibition is unclear. Here, we elucidate how polyphenols modify the self-assembly of functional
amyloid, with particular focus on epigallocatechin gallate (EGCG), penta-O-galloyl-β-d-glucose
(PGG), baicalein, oleuropein, and procyanidin B2. We find EGCG and PGG to be the best inhibitors.
These compounds inhibit amyloid formation by redirecting the aggregation of FapC monomers into
oligomeric species, which according to small-angle X-ray scattering (SAXS) measurements organize
into core-shell complexes of short axis diameters 25–26 nm consisting of ~7 monomers. Using peptide
arrays, we identify EGCG-binding sites in FapC’s linker regions, C and N-terminal parts, and high
amyloidogenic sequences located in the R2 and R3 repeats. We correlate our biophysical observations
to biological impact by demonstrating that the extent of amyloid inhibition by the different inhibitors
correlated with their ability to reduce biofilm, highlighting the potential of anti-amyloid polyphenols
as therapeutic agents against biofilm infections.
Keywords: bacterial amyloid; FapC protein; extracellular matrix; aggregation inhibitor; peptide array
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1. Introduction
Functional amyloids are formed from proteins secreted by microorganisms which self-assemble
extracellularly toβ-sheet-rich fibrillar aggregates [1], typically in the form of long, needle-like structures.
Unlike misfolded proteins involved in amyloid-related diseases like Parkinson’s and Alzheimer’s [2,3],
expression and release of these functional amyloidogenic proteins is meticulously controlled in biofilm
formation and leads to useful biological properties such as coating of endospores, stabilization,
and increased antibiotic resistance [4,5]. Functional amyloids are particularly widespread in bacteria,
e.g., curli in Escherichia coli, TasA in Bacillus subtilis, phenol-soluble modulins in Staphylococcus aureus,
and Fap in Pseudomonas strains [6,7]. They serve a multitude of purposes in these bacteria [7,8].
In the case of the opportunistic pathogen Pseudomonas aeruginosa, associated with chronic airway
infections of cystic fibrosis patients [9,10], amyloid in the extracellular matrix mechanically strengthens
bacterial biofilm [11,12]. This increases bacterial resistance to antibiotics and environmental stress [13]
and underpins chronic wound infections. Unlike pathological amyloid in e.g., neurodegenerative
diseases, production and secretion of functional amyloid is carefully regulated by a number of helper
proteins. Thus, the major component of this amyloid is the protein FapC, produced by the fap operon
(Fap A-F) which also codes for other proteins which facilitate extracellular secretion of FapC. Of these,
FapF forms a trimeric porin in the outer membrane [14] with an extended coiled-coil domain that may
facilitate transport across the periplasm [15]. FapB, which is found at low levels in mature fibrils [16]
and is believed to act as a nucleator to facilitate rapid FapC fibrillation. Control of functional amyloid
formation is also seen at the level of the protein sequence. FapC from different Pseudomonas species
share three imperfect repeats (R1–R3) separated by two linkers of variable size [4]. In Pseudomonas sp
UK4, FapC consists of 250 residues, including a 24-residue signal sequence. Stepwise removal of the
different repeats, particularly R3, destabilizes the ensuing FapC fibrils (L.F.B. Christensen and D.E.O.,
unpublished results) and increases the tendency of the fibrils to fragment during fibrillation [17].
Polyphenolic compounds constitute a large group of small molecule metabolites with antioxidant
properties and a range of promising disease-fighting properties [18], not the least against protein
aggregation [19,20]. Plants and fruits are natural sources of polyphenols such as epigallocatechin gallate
(EGCG, found in green tea), the gallotannin penta-O-galloyl-β-d-glucose (PGG, pomegranates, sumac,
mango seeds), baicalein (root of the flowering plant Scutellaria baicalensis), oleuropein (green olive leaves,
skin, and flesh) and procyanidin B2 (apple, grape, litchi, and cinnamon), whose structures are shown
in Figure 1A. EGCG directly binds to the thick peptidoglycan layer of gram-positive bacteria where it
may attack gram-negative bacteria through the production of H2O2 [21]. EGCG also interferes with
bacterial quorum-sensing and affects biofilm formation by reducing autoinducer-2 concentration [22].
In addition, a range of polyphenols inhibits formation of a broad range of amyloids [23,24], not the least
FapC from P. aeruginosa PAO1 where it commensurately increases biofilm sensitivity to antibiotics [25].
EGCG has been suggested to redirect otherwise amyloidogenic monomers to off-pathway oligomers
through interactions between its pi-system and the protein backbone [26], though interactions with
hydrophobic regions and H-bonding partners also contribute [27,28]. We have recently shown that
EGCG inhibits FapC fibrillation even in the presence of bacterial amphiphiles such as rhamnolipids
and LPS which otherwise promote fibrillation [29]. PGG is reported to have applications against cancer,
diabetes, inflammation, neurodegeneration, viruses, and bacteria [30–36], but also inhibits aggregation.
For example, it binds to the N-terminus and central hydrophobic core of Aβ1–42 and Aβ1–40, decreasing
formation of both oligomers and fibrils [37].
Given the evolutionary optimization of the properties of functional amyloid in contrast to
their pathological counterparts, polyphenol inhibitors might impact their fibrillation in a different
manner. To investigate this, we have compared the activities of a number of different polyphenols
against the fibrillation of FapC wildtype (wt) and truncations thereof. Starting with a broad range of
polyphenols, we select EGCG, PGG, baicalein, oleuropein, and procyanidin B2 as the most promising
candidates. Based on a broad range of biophysical measurements, we identify EGCG and PGG
as the best inhibitors. They redirect FapC to off-pathway oligomers in the form of a compact core
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surrounded by a flexible shell, remarkably similar to oligomers formed by the pathological amyloid
protein α-synuclein. In addition, we use deletion mutants of FapC and peptide arrays to identify
which parts of the FapC sequence are involved in these processes. Finally, we show that the inhibitors
reduce biofilm formation in Pseudomonas UK4 overexpressing the fap-operon to an extent which
correlates with their amyloid-inhibiting properties, highlighting their therapeutic potential against
biofilm-mediated infections.
2. Materials and Methods
2.1. Purification of His-Tagged Recombinant FapC Protein
His-tagged FapC (wt and mutants) were purified as described [17] and stored in 8 M GdmCl.
Immediately prior to use, FapC was desalted into 50 mM Tris pH 7.5 with PD-10 columns [17].
2.2. Thioflavin T Fibrillation Assay
30 µM FapC was incubated in Tris buffer (50 mM, pH 7.5) with 40 µM ThT and different
concentrations of inhibitors (from stocks of 100 mM in DMSO). Note that the low residual amounts
of DMSO from the stock solution did not affect fibrillation kinetics (Figure S1A). The solutions were
monitored in a 96-well plate (Nunc, Thermo Fisher Scientific, Roskilde, Denmark) at 37 ◦C with
180 rpm orbital shaking together with a sterile 3 mm diameter glass bead, using excitation and emission
at 448 and 485 nm, respectively from the plate bottom on a Genios Pro fluorescence plate reader
(Tecan, Männedorf, Switzerland). The plate was sealed with clear crystal sealing tape (Hampton
Research, Aliso Viejo, CA, USA) to prevent evaporation. Additional experiments at different FapC
concentrations (30, 50, and 90.6 µM) and different concentrations of EGCG and Baicalein under
quiescent conditions were carried out in a Clariostar plus plate reader (BMG Labtech, Ortenberg,
Germany) using the following settings: Excitation: 448.2 nm, emission: 485 nm, gain: 1500, scan mode:
Orbital averaging, scan diameter: 4 mm, cycle time: 5 min. Endpoint ThT fluorescence levels were read
out directly from the raw data as the average from the 5 h of the fibrillation process, while nucleation
(lag) times tN were estimated as the intercept between the base line and the elongation phase.
2.3. Reverse Phase High-Performance Liquid Chromatography (RP-HPLC)
100 µM of polyphenol in 50 mM Tris buffer pH 7.5 was incubated on an Eppendorf thermo-shaker
TS-100 (BioSan, Riga, Latvia) at 37 ◦C at 300 rpm. After 0, 1, 2, 4, 8, 16, and 24 h of incubation, 20 µL of
the samples were injected onto a C18 column (RP-C18 Luna column, 4.6 mm id × 250 mm, Phenomenex,
Cheshire, UK) and elution was monitored by absorption at 270 nm. Materials were eluted using
a mobile phase of 30:70 v/v acetonitrile: Water at a flow rate of 0.5 mL/min for all polyphenols except for
the more hydrophobic compound baicalein where the mobile phase consisted of 80:20 v/v acetonitrile:
Water [38].
2.4. Circular Dichroism (CD) Spectroscopy
Fibrillated samples were sonicated for 10 min in a Sonorex Digitec ultrasonic bath (Bandelin,
Berlin, Germany) and diluted to 15 µM in Tris buffer (50 mM, pH 7.5). Spectra for fibrils and monomers
were recorded on a Chirascan CD spectrophotometer (Applied Photophysics, Surrey, UK) in a 1 mm
cuvette between 200 and 260 nm with 3-nm bandwidth at 25 ◦C and three accumulations.
2.5. Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (ATR-FTIR)
To remove unbound polyphenols, fibrillated samples were centrifuged (13,000 rpm for 15 min),
supernatants discarded, and the pellet resuspended in the same volume of milliQ water. 2 µL was
dried under a stream of nitrogen and spectra recorded on a Tensor 27 FTIR spectrophotometer (Bruker,
Billerica, Massachusetts, USA) with a DTGS (deuterated tri-glycine sulfate) Midinfrared detector and
Golden Gate single reflection diamond attenuated total reflectance cell (Specac, Kent, UK). Baseline
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correlation, atmospheric compensation, and second derivative of curves were carried out with OPUS
5.5 software (Bruker, Billerica, Massachusetts, USA).
2.6. Seeding Experiments
FapC fibrils and aggregates formed in the presence of polyphenols were pelleted (13,000 rpm
for 15 min), supernatant removed, and pellet resuspended in the same volume of milliQ water.
The suspension was sonicated with 20% amplitude for 2 min (pulse 5 s on and 5 s off) on a QSonica
Sonicator (Q500, Newtown, CT, USA) to obtain short fibrils. 30 µM of FapC monomer was incubated
with 2% and 10% (w/w) of seeds using the Tecan settings above without agitation. Polyphenols were
included at 120 µM.
2.7. Formic Acid Assay
30 µM FapC monomer was incubated with and without 120 µM PGG as described for the
fibrillation assay. After reaching the stationary phase in the fibrillation process, the aggregates were
washed twice with milliQ water by centrifugation (13,000 rpm for 15 min) and resuspended in different
FA concentrations in water (30%–70%), incubated for 15 min at room temperature, frozen, and freeze
dried overnight to remove FA. Dried samples were resuspended in Tris buffer and loaded on 15%
acrylamide-bis SDS-PAGE.
2.8. Detection of Polyphenols by Nitro Blue Tetrazolium (NBT-Assay)
FapC monomer incubated with EGCG at different time points were loaded on two 12% SDS-PAGE
gel with prestained protein ladder (Thermo Scientific, Roskilde, Denmark). One gel was stained
with Coomassie Brilliant Blue to visualize protein bands. The other gel was electroblotted onto PVDF
membrane (Merck Millipore, Darmstadt, Germany) for 1 h at 200 mA, after which the membrane was
stained with NBT solution (0.6 mg/mL NBT, 2 M potassium glycinate at pH 10) in the dark for 45 min.
The membrane was washed with 0.64 M boric acid at pH 9.0 and then with milliQ water and scanned
with an image scanner.
2.9. Celluspots™ Peptide Arrays
Peptide arrays were prepared as described [39]. Each peptide array was blocked with 25 mL
blocking solution (PBS with 0.1% Tween-20 (PBS-T) containing 3% (w/v) whey protein powder) in
a Nunc™ tube on a rolling board overnight at 4 ◦C. Two arrays were incubated with or without
0.05 mg/mL EGCG (dissolved in PBS-T pH 7.5) for 6 h on a rolling board at room temperature
(25 ◦C), washed three times with PBS-T and three times in milliQ water. Subsequently the plates were
submerged in NBT-T (0.6 mg/mL NBT, 2 M potassium glycinate, 0.1% Tween-20, pH 10) solution for
45 min in the dark, washed with boric acid solution and milliQ water, left to dry for ~5 min and imaged
using a scanner. Results were converted to signal intensities with the protein array analyzer toolbox in
Image J.
2.10. Size Exclusion Chromatography (SEC)
Samples were centrifuged (13,000 rpm for 10 min) and the supernatants were loaded on a 24 mL
Superose 6 10/300 column (GE Healthcare, Brondby, Denmark) at a flow rate of 0.5 mL/min and
absorbance were recorded at 280 nm (Agilent 1260 Analytical UV cell). Oligomers were purified by
fractionation of the output current and concentrated using an Amicon Ultra-15 centrifugal filter with
15 kDa molecular weight cut-off.
2.11. Small-Angle X-ray Scattering (SAXS)
Oligomer samples were purified by SEC and measured together with freshly desalted samples
of FapC, FapC with TCEP, the mutant ∆R1R2R3 with and without TCEP. Buffers were measured for
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background subtraction. The protein concentration determined at 280 nm with a NanoDrop™ 1000
spectrophotometer (Thermo Scientific, Roskilde, Denmark) based on the extinction coefficient of FapC
monomer (10,095 M−1 cm−1). All experiments were carried out on an in-house modified NanoSTAR
SAXS instrument (Bruker AXS) [40] with a Ga liquid metal yet source (Excillum) [41] and scatterless
slits [42]. The SUPERSAXS package (C.L.P. Oliveira and J.S.P., unpublished) was used for initial data
treatment, buffer subtraction, and absolute scale normalization using water. All data are displayed as
a function of the modulus of the scattering vector q = 4pi/λ sin(θ), with 2θ being the scattering angle and
λ = 1.34 Å. The home-written program WIFT [43] was used to carry out indirect Fourier transformation
(IFT) [44] and obtain the pair distance distribution function (p(r)), which is a histogram of distances
in the sample weighted by the excess electron density. The IFT gives information on the average
size of molecules in the solution in terms of radius of gyration (Rg) and also on the molar mass (Mw)
through the forward scattering (I(q = 0)), which can be converted into Mw using a protein contrast
value of ∆ρm = 2.00 × 1010 cm/g and the relation M = I(0)/(c ∆ρm2), where c is the protein concentration.
The mass can be converted into an aggregation number of the protein (Nagg) by dividing by the mass
of the monomeric protein. To model the oligomers, we used a core-shell model with a compact core
surrounded by a shell of flexible protein as described [45]. Modelling was done on an absolute scale to
obtain Nagg. Smearing of the electron density was used in both the core (σin) and the shell (σout) using
a smearing function of e−q2σ/2. Furthermore, the core was described as a prolate ellipsoid with the long
axis being multiplied by ε and the core radius was set to Rcore = 2 σin and the shell radius to Rshell = 2
σin + 2 σout. The total size of the complex was determined by the diameter = 8 σin + 4 σout along the
short axis of the ellipsoidal structure. The fraction of mass in the shell (f shell) was determined from the
size of the core compared to the shell and used to calculate the polymer scattering arising from the
flexible region in the shell. Scattering contributions from added polyphenols were ignored due to their
insignificant contributions.
2.12. Measuring Amount osf Biofilm with Crystal Violet
A single colony of Pseudomonas sp. UK4 (wt, ∆fap, and pfap) was transferred to the LB medium at
28 ◦C, 180 rpm for overnight growth. The solutions were then diluted to OD600~0.5 in the presence of
ampicillin (100 µM) to avoid contamination, and 160 µL hereof added to each well of a 96-well plate.
Peg lids (Nunc-Tsp, Thermo Scientific, Roskilde, Denmark) were inserted in the plate wells for 1 h to
initiate biofilm growth on the peg lids, after which the peg lids were transferred to another fresh LB
medium (160 µL per well) with 100 µM polyphenol for 48 h incubation, resulting in growth of biofilm
on pegs. The peg lids were then washed in milliQ water to remove planktonic bacteria and dried
for 1 h at room temperature, after which they were submerged in a new plate with 160 µL per well
Gram’s crystal violet solution for 15 min. The peg lid was washed twice with milliQ water to remove
excess stain and bound crystal violet was released by incubation of the peg lids in 33% v/v acetic acid
(glacial acetic acid diluted with milliQ water) for 30 min at room temperature. The absorbance intensity
at 590 nm was used as a measure of the amount of biofilm on the pegs.
2.13. Confocal Microscopy
One colony of Pseudomonas sp. UK4 (wt, ∆fap, and pfap) was transferred to the LB medium
for overnight growth at 28 ◦C, 180 rpm, diluted to OD600~0.5, and transferred to an IBIDI® µ-slide
VI0.4 uncoated channel slide. After 1 h incubation, the bacteria were gently washed with fresh LB
medium, after which the LB medium with 100 µM of PGG and EGCG was circulated through the
chambers at a flow rate of 2 mL/h for 48 h (Harvard PHD 2000 Infuse/Withdraw Syringe Pump) to
enable formation of biofilm under dynamic conditions. After washing the chambers with PBS and
staining with live/dead kit using Cyto9 and propidium iodide, bacteria were imaged with LSM 510
scanning confocal microscope (Zeiss GmbH, Jena, Germany).
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3. Results
3.1. Polyphenols Inhibit FapC Fibrillation by Forming Non-Amyloid Aggregates
As an initial step, we compare the ability of ten different polyphenols to inhibit FapC
fibrillation. These ten compounds are PGG, EGCG, oleuropein, baicalein, procyanidin-B2, verbascoside,
3-hydroxytyrosol, epicatechin, catechin, and gallic acid (Figure S1C). All ten compounds
contain multiple vicinal hydroxyl groups, ranging from single aromatic rings (gallic acid and
3-hydroxy-terosol) to complex systems linked through a glucose ring (PGG); furthermore, gallic
acid and catechin/epicatechin are subscaffolds of EGCG, procyanidin, and PGG. We incubated 30 µM
wt FapC monomer with 10–200 µM polyphenols (Figure S1B), monitoring fibril formation with the
amyloid-binding dye Thioflavin T (ThT, representative runs in Figure 1B,C). All compounds decrease
ThT end-point emission in a dose-dependent fashion (Figure 1D, S1B), with PGG showing the strongest
effect, followed by baicalein, EGCG, procyanidin B2, and oleuropein. The remaining five compounds
showed significantly weaker effects, indicating that a reduction in compound size below a certain level
of complexity leads to a loss of activity. Accordingly, we proceed with the five best polyphenols.
Biomolecules 2019, 9, x 7 of 22 
Biomolecules 2019, 9, x; doi: www.mdpi.com/journal/biomolecules 
 
 
Figure 1. Effect of polyphenols on fibrillation-prone protein (FapC)-UK4 fibrillation. (A) Structures of 
compounds used in this study. Compound colors correspond to the label colors in subsequent graphs; 
(B) time course of fibrillation of 30 µM FapC with 100 µM polyphenols at pH 7.5 and 37 °C monitored 
by Thioflavin T (ThT) fluorescence (C) and zoom-in in (A); (D) IC50 values for inhibition of fibrillation 
based on data in panel b; (E) SDS-PAGE of samples after incubation with polyphenols. Red box 
highlights the oligomer band; (F) Circular Dichroism (CD) and (G) ATR-FTIR of samples from panel 
A after the end of incubation. 1623 and 1663 cm−1 peaks are attributed to β-sheet; (H) correlation 
between ATR-FTIR/CD and ThT endpoint levels. 
Reduction of ThT fluorescence could be caused either by a genuine reduction of the amount of 
fibrils formed or by the displacement of ThT from amyloid by polyphenols, i.e., a misleading artifact. 
To resolve this, we analyzed the samples at the end of the fibrillation process using different 
structural techniques. According to the far-UV circular dichroism (CD), all samples had significant 
β-sheet structures with a minimum around 218 nm, though with reduced intensity, particularly for 
PGG and EGCG (Figure 1F). For complementary data on the secondary structure, we used ATR-FTIR 
(attenuated total reflectance Fourier transform infrared spectroscopy). The 2nd derivative spectrum 
(Figure 1G) in the control (compound-free) FapC fibrils highlighted the characteristic amyloid peak 
around 1623 cm−1 as well as a smaller peak at 1663 cm−1 indicative of antiparallel β sheets [47]. These 
peaks almost disappear for PGG and EGCG and diminish to some extent for oleuropein, procyanidin 
B2, baicalein, and control. CD and FTIR thus confirm reduction in β-sheet content by both PGG and 
EGCG; more specifically, we observe a strong linear correlation between end-point ThT intensities 
and CD as well as FTIR signals (Figure 1H). Therefore, the endpoint ThT fluorescence is an accurate 
-5.0 -4.5 -4.0 -3.5
0
20
40
60
80
100
Log[Polyphenols]
EGCG
OP
BC
PC-B2
PGG
IC50 ( M)
26  1.09
38  1.11
101  1.08
46  1.13
97  1.07
(D)
Figure 1. Effect of polyphenols on fibrillation-prone protein (FapC)-UK4 fibrillation. (A) Structures
of compounds used in this study. Compound colors correspond to the label colors in subsequent
graphs; (B) time course of fibrillation of 30 µM FapC with 100 µM polyphenols at pH 7.5 and 37 ◦C
monitored by Thioflavin T (ThT) fluorescence (C) and zoom-in in (A); (D) IC50 values for inhibition
of fibrillation based on data in panel b; (E) SDS-PAGE of samples after incubation with polyphenols.
Red box highlights the oligomer band; (F) Circular Dichroism (CD) and (G) ATR-FTIR of samples from
panel A after the end of incubation. 1623 and 1663 cm−1 peaks are attributed to β-sheet; (H) correlation
between ATR-FTIR/CD and ThT endpoint levels.
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We used RP-HPLC to assess compound stability over 24 h at 37 ◦C pH 7 (Figure S2). While the
population of the starting compound declined by 40%–70% over 24 h, the compounds were largely
stable (2%–25% loss) over the first 2 h, corresponding to the lag phase of FapC fibrillation (Figure 1).
Thus, the compounds are essentially intact during this critical time period where fibrillation would
otherwise start to occur. Furthermore, the compounds form stable adducts with FapC within the first
hour of incubation (see below).
SDS-PAGE analysis of the soluble fraction from the ThT end-point samples revealed high molecular
weight bands only for PGG and EGCG, but in all cases only a small amount of monomeric FapC
(226 residues for the mature protein, molecular weight 22.5 kDa but migrating with an apparent weight
of ≈31 kDa) (Figure 1E). Larger aggregates (fibrils or other kinds of aggregate probably produced
by effect of polyphenols) will not enter the gel. Thus, most of FapC must assemble into aggregates
of some kind even in the presence of polyphenols. Note that a ~25 kDa band was visible migrating
below the monomer. Previous work studying proteins recombinantly expressed in E. coli and purified
by Ni-NTA chromatography attribute this 25 kDa band to the protein SlyD, whose high content of
His residues in its C-terminus leads to a relatively high affinity for the Ni-NTA column used during
purification of both FapC and CsgA [46].
Reduction of ThT fluorescence could be caused either by a genuine reduction of the amount of
fibrils formed or by the displacement of ThT from amyloid by polyphenols, i.e., a misleading artifact.
To resolve this, we analyzed the samples at the end of the fibrillation process using different structural
techniques. According to the far-UV circular dichroism (CD), all samples had significant β-sheet
structures with a minimum around 218 nm, though with reduced intensity, particularly for PGG and
EGCG (Figure 1F). For complementary data on the secondary structure, we used ATR-FTIR (attenuated
total reflectance Fourier transform infrared spectroscopy). The 2nd derivative spectrum (Figure 1G) in
the control (compound-free) FapC fibrils highlighted the characteristic amyloid peak around 1623 cm−1
as well as a smaller peak at 1663 cm−1 indicative of antiparallel β sheets [47]. These peaks almost
disappear for PGG and EGCG and diminish to some extent for oleuropein, procyanidin B2, baicalein,
and control. CD and FTIR thus confirm reduction in β-sheet content by both PGG and EGCG; more
specifically, we observe a strong linear correlation between end-point ThT intensities and CD as
well as FTIR signals (Figure 1H). Therefore, the endpoint ThT fluorescence is an accurate reporter
of the amyloid amounts and can be used to calculate the apparent IC50 value where the end-point
ThT level has been reduced to 50% of the original value (Figure 1D). This ranked the compounds as
PGG > baicalein ≈ EGCG > procyanidin B2 ≈ oleuropein in terms of inhibitory potency.
Consistent with the observation of high-molecular weight bands in Figure 1E, TEM of samples
with PGG and EGCG shows small spherical species with diameters around 19 ± 1 nm whereas the
other three polyphenols give rise to fibrils with an average width of 13 ± 1 nm width, surrounded by
more amorphous aggregates (Figure 2).
The formation of non-amyloid aggregates with PGG and EGCG, whose presence is not captured by
our ThT assay, significantly complicates a kinetic analysis of the data. Although the effect of inhibition
can be attributed purely to a depletion of the monomer concentration into non-amyloid aggregates
over the course of the aggregation reaction, the concentration of non-amyloid aggregates over time,
and thus also the monomer concentration, is not known. EGCG shows a longer lag phase than baicalein
(Figure 1C) but reaches the same endpoint ThT level. This may reflect the different kinetics of the
formation of the non-amyloid species. By examining the early time behavior of the data (Figure 1C) it
is clear that amyloid forms at comparable rates to the inhibitor-free case in the presence of oleuropein
and procyanidin, but forms significantly more slowly in the presence of baicalein, PGG and EGCG.
Assuming that the inhibitory effect is purely an indirect one via depletion of monomers, this finding
indicates that a significant level of non-amyloid structures has been reached after 1 h in the presence of
PGG, EGCG, and baicalein.
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Given that PGG was the best inhibitor of FapC amyloid formation, we decided to investigate the
stability of the non-fibrillar aggregates formed in the presence of this polyphenol. Many pathological
fibrils dissolve at very low concentrations of the potent denaturant formic acid (FA); in contrast,
functional amyloid typically requires > 80% FA for complete dissolution [11]. The aggregates were
spun down and exposed to different concentrations of FA, lyophilized (to remove FA), and analyzed
by SDS-PAGE. There is a marked difference between aggregates in samples with PGG and fibrils
in polyphenol-free samples (Figure S3). With PGG, aggregates resist up to 40% FA, above which
they gradually dissociate to a mixture of monomers, dimers, and higher-order oligomeric species.
In contrast, FapC fibrils only form monomers and a very small amount of dimers. The monomers
already start to form from 30% FA onwards, emphasizing the difference between the two aggregate
types and indicating a strong stabilization of non-amyloid aggregates by PGG.
To investigate whether the polyphenols inhibit growth of FapC fibrils, 10% (v/v) sonicated FapC
fibrils were used to seed solutions of monomeric FapC with and without polyphenols (raw data in
Figure S4, summarized in Figure 3A). At these high seed concentrations, the kinetics are dominated
almost purely by growth of existing fibrils and ucleation of free mon mers is essentially negli ible.
Both alone and in the presence of the different polyphenols, except for PGG, the seeds completely
abolish the lag phase of normal FapC fibrillation. PGG completely suppress the ThT sign l growth.
The endpoint fluore cence o th se samples was c nsistently lower than in the absence of seeds,
indicating that t non-a yloi speci s are formed rapidly compared to the timescale of fibril
elongation, even in the absence of nucleation.
The ensuing aggregates were then used in a second assay to evaluat the seeding capacity of
aggregates formed in the presence of inhibitors. Each sample was spun down after fibrillation to
remove unbound polyphenols and monom ric F pC inhibitors, after which the aggreg tes wer
resu pended in water, sonicated, and added t 2% and 10% (v/v) of FapC monomer in the absence
of additional polyphenols (Figure 3B,C). In all cases, the seeds eliminate the lag phase but the rise in
ThT fluorescence is reduced to a small extent in a ranking order consistent with the previous inhibitor
performance of the polyphenols. Thus, the end-level aggregates formed by the different inhibitors do
retain the ability to promote FapC fibrillation but to a slightly reduced extent.
3.3. Increased Nucleation Times Increase the Inhibitory Effects of Polyphenols
For comparison we turned to the closely related FapC-PAO1 from P. aeruginosa, which differs from
FapC-UK4 in having a significantly longer linker region between repeats 2 and 3. Polyphenol effects
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were broadly similar to those on FapC-UK4. FapC-PAO1 has a 3–4 fold longer lag phase than the FapC
UK4 without inhibitor (Figure 4A) and this is further increased by baicalein, PGG, and EGCG. It is
possible that the increased lag phase of FapC-PAO1 may enhance its susceptibility to polyphenols, just
as the most slowly aggregating FapC-UK4 mutant, but not the faster variants, inhibits aggregation of
α-synuclein [48]. However, the end-point ThT fluorescence and nucleation (lag) times tN (normalized
to values in the absence of polyphenols) are broadly similar between the two FapC variants and once
again show that PGG, EGCG, and baicalein are the most efficient inhibitors. Further, PGG, EGCG, and
baicalein keep FapC monomeric or lead to off-pathway oligomers (Figure 4B).
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Figure 3. Seeding experiments to test the ability of different aggregates to promote fibrillation of
monomeric FapC-UK4. (A) Seeds: FapC fibrils. Solution: Monomeric FapC (30 µM) together with
polyphenols (120 µM); (B,C) seeds: Aggregates of FapC formed in the presence of 2% and 10% (v/v)
polyphenols and spun down. Solution: Monomeric FapC (30 µM). The indicated labelling scheme
applies to both (B,C).
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of end-point samples from panel A. Epigallocatechin gallate (EGCG), penta-O-galloyl-β-d-glucose
(PGG), and Baicalein maintain FapC in the monomeric or oligomeric state and inhibit fibrillation;
(C) normalized end-point ThT levels and lag times of FapC fibrillation with different polyphenols.
T expand on these initial observations, we turned to mutants of FapC-UK4 in which ne, two,
or three of the imperfect repeats had been removed. The deletion mutants allow us to investigate
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if some regions of FapC are particularly important for interactions with the polyphenols (ThT time
profiles in Figure S5). The lag phase increases particularly in mutants lacking the R3 repeat (Figure 5A).
This indicates that R3 is the most aggregation prone repeat, consistent with previous results [17].
PGG and EGCG considerably reduced the intensity of ThT-emission and increased tN for all mutants
(Figure 5B,C).
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We used SDS-PAGE to monitor the amount of soluble species of the different FapC-UK4 mutants
left at the end of aggregation in the presence of polyphenols (Figure S6, summarized in Figure 5D,E).
This provided further evidence for the link between longer nucleation times and greater effect of
inhibitors. Overall, the longer the lag phase, the greater the tendency for FapC-UK4 to be maintained
as monomer or off-pathway oligomers, particularly in the presence of PGG and EGCG. This is clearly
seen for mutants lacking repeat R3, most strongly for the mutant lacking all three repeats which
failed to fibrillate both according to ThT (Figure S5G) and TEM (Figure S7B). TEM images of mutants
incubated without and with EGCG (Figure S7A,B) confirmed that EGCG drove formation of large
amounts of oligomers in R3-free mutants according to SDS-PAGE. To increase the lag phase further, we
incubated wt FapC-UK4 without agitation (Figure S8A) and analyzed the content of the end-phase
samples by SDS-PAGE (Figure S8B). Quiescence increased the lag phase of the control sample from 1
to 5 h. Comparison with Figure 1B and 1D shows that quiescence also leads to a marked decrease in
normalized ThT fluorescence for all compounds (Figure S8B) as well as a significant increase in the
concentration of both oligomer and (unpolymerized) monomer, particularly for EGCG (Figure S8C).
Note that deletion of R2 in the ∆R2,3 mutant prolongs the lag phase more than the deletion of R1
in ∆R1,3 FapC (Figure 5A). The SDS-PAGE of FapC variants incubated with EGCG also show stronger
oligomer and monomer bands for ∆R2,3 than ∆R1,3 (Figure 5D) that could be due to longer lag phase
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of ∆R2,3. The considerable amount of oligomer formation of mutant ∆R1,2,3 in the presence of PGG
and EGCG (Figure S6A—∆R1,2,3 and Figure S7B) indicates that the linker regions provide interaction
sites for polyphenols (see below).
3.4. PGG and EGCG Bind to FapC Monomers and Early Oligomers to Inhibit Fibril Formation
Our inhibition results prompted a closer investigation of their interaction with monomers and
soluble aggregates of FapC. We exploited that the compound nitroblue tetrazolium (NBT) is converted
to dark-purple formazan by compounds containing quinones such as EGCG [25]. Accordingly,
we concentrate on EGCG in the following. Oligomers were purified by SEC, separated on SDS-PAGE,
transferred to PVDF membranes, and finally stained with NBT (Figure 6A). There was a good
correspondence between species seen by Coomassie staining and NBT, indicating that all species were
able to bind to EGCG. However, the smaller species could conceivably derive simply from dissociation
of the oligomers. To address whether monomers also react with EGCG, we followed the evolution
of different species over time with NBT staining, which highlights both monomeric and oligomeric
species formed over the first 8 h (Figure 6B). Nevertheless, the oligomers show up more clearly by NBT
than Coomassie staining, indicating stronger interactions with these species. There is a gradual fading
of the NBT color over time which may also be due to slow oxidative modifications of EGCG.
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corresponding to different sequences of FapC, incubated with EGCG, and stained with NBT to 
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Finally, we probed the binding of EGCG to different parts of the 226-residue mature FapC-UK4 
sequence (i.e., without the 24-residue signal peptide sequence). For this we used a peptide microarray 
that displays the whole protein as 10-residue peptides displaced five residues along the sequence, 
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Figure 6. NBT-assay demonstrating polyphenol interactions with FapC. (A) Right: SDS-PAGE of
oligomers separated by SEC, left: A copy of the same SDS-PAGE gel was electroblotted onto PVDF
membrane and stained with NBT; (B) time study of the EGCG-FapC interaction using (right) SDS-PAGE)
and (left) NBT-stained PVDF membrane, respectively. Samples were taken out at the indicated times
and frozen before running on the gel; (C) signal intensities of peptide array displaying peptides
corresponding to different sequences of FapC, incubated with EGCG, and stained with NBT to identify
interacting sequences.
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Finally, we probed the binding of EGCG to different parts of the 226-residue mature FapC-UK4
sequence (i.e., without the 24-residue signal peptide sequence). For this we used a peptide microarray
that displays the whole protein as 10-residue peptides displaced five residues along the sequence,
giving each peptide spot a five-residue overlap with the next spot. The extent of EGCG binding to
each spot is quantified by NBT-staining followed by densitometric analysis with Image J. A control
array that was not exposed to EGCG did not develop any color with NBT (Figure S9). The intensity of
EGCG binding varied significantly across the probed peptides (Figure 6C), showing particular affinity
for regions corresponding to the very N-terminal part, a highly amyloidogenic sequence in repeats
R2 and R3 (but not R1) based on Rosetta energy calculations [39], linkers between R1–R2 and R2–R3,
and the very C-terminal part. There was no clear correlation with hydrophobicity or aromaticity (data
not shown). The strong binding to linker regions rationalizes the effect of EGCG on the triple mutant
of FapC (∆R1,2,3) which only includes the linker regions; however it does not explain the variation
in oligomer production by different FapC variants (Figure 5D), as they all contain linker regions.
Presumably it is the combination of EGCG binding sites and their accessibility through prolonged lag
phases that facilitates oligomer accumulation.
3.5. Polyphenols Have Different Potential for Assembly of Off-Pathway Oligomers
As shown by SDS-PAGE (Figure 4B), the polyphenols lead to accumulation of oligomers to
different extents, but it was not a priori clear whether the size and shape of these oligomers differed
among the different polyphenols. Accordingly, we quantified oligomer concentration by SEC after
1 h of incubation with polyphenols. There was a direct correlation between the inhibitory effect and
oligomer amount (Figure 7A). PGG and EGCG led to significantly larger oligomer peaks (eluting
around 25 mL) than the other polyphenols which in turn outperformed the control. To monitor the
oligomer development over time, we analyzed population sizes with SEC after different incubation time
points. We compare the best inhibitor (PGG), the worst (oleuropein), and control (Figure 7B–D). In all
cases, the oligomer concentration declines over time and disappears completely after 24 h. PGG leads
to the largest oligomeric species which declines slowly in intensity over 24 h, while oleuropein and
control only lead to small amounts of a species which is probably a small oligomeric (e.g., dimer and
trimer) mixture, eluting as a shoulder on the monomer peak. This peak disappears within a few hours,
most likely it is being incorporated into growing fibrils. The peaks eluting after monomer in SEC are
attributed to polyphenols due to their long retention and lack of signal on SDS-PAGE (data not shown).
The high signal intensity of the PGG oligomers (significantly higher than that of the monomers) can be
ascribed to the PGG bound to the oligomers, cf. NBT-staining (Figure 5A).
To investigate the oligomer structure, we purified oligomers prepared in the presence of PGG,
EGCG, and Baicalein and analyzed them by TEM, SAXS, and CD. TEM images displayed remarkably
monodisperse spherical oligomers with a diameter around 18 nm in the presence of inhibitors while
the size of the control oligomers was around 10 nm (Figure 8A control). The oligomers show the
same random coil spectrum as monomeric FapC (Figure 8B). All three off-pathway oligomers showed
a highly similar SAXS scattering pattern (Figure 8C,D). The pair-distance distribution function (p(r)),
which is a histogram over distances between pair of points within the particle, was determined
by indirect Fourier transformation (IFT). The main feature between 0 and 20 nm indicated that the
PGG, EGCG, and baicalein oligomers all had a somewhat compact structure and a radius of gyration
(Rg) for the whole oligomer (core and shell) of 10.1 ± 0.2, 7.2 ± 0.1, and 10.0 ± 0.2 nm, respectively
(Table 1). We were able to fit to the data with a model developed for α-synuclein oligomers [45],
in which a compact prolate ellipsoidal core is surrounded by a shell of flexible protein (Figure 8E).
This model could describe all three oligomers and gave short axis diameters of 27.2 ± 0.5, 25.6 ± 0.3,
and 25.8 ± 0.4 nm and similar aggregations numbers (Nagg) of 7.6 ± 0.2, 6.7 ± 0.1, and 6.7 ± 0.1 for PGG,
EGCG, and baicalein, respectively. No change in the structure of the oligomers was seen when they
were incubated at 37 ◦C for 16 h (data not shown). The thickness of the flexible shell was similar for all
three oligomers with 0.31–0.36 of the total protein mass being located in this region. The shown values
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of Nagg in Table 1 were determined from the determined p(r) function, and they are similar to values
obtained by the modeling (data not shown).
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Figure 7. SEC- and SDS-PAGE-based analysis of FapC oligomers formed in the presence of polyphenols.
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and run on SDS-PAGE; (B–D) time course of oligomer formation: SEC profiles over time of FapC
incubated with (B) PGG, (C) oleuropein, and (D) without inhibitor.
Table 1. SAXS data for monomers and SEC-purified oligomers of FapC.
Sam les Mw (kDa) a Naggb
Rg, shell
(nm) c
Rg, total
(nm) d
fShelle
Diameter
(Short Axis)
(nm)
Diameter
(Long Axis)
(nm)
Monomers (freshly desalted)
FapC-TCEP 34.7 ± 1.0 1.4 ± 0.1 5.9 ± 0.1
FapC 109 ± 3 4.4 ± 0.2 10.1 ± 0.2
∆R1R2R3 38.9 ± 1.4 2.7 ± 0.1 7.0 ± 0.1
∆R1R2R3-TCEP 26.1 ± 0.9 1.8 ± 0.1 5.9 ± 0.2
Oligomer samples purified by SEC
∆R1R2R3-PGG 60 ± 1 4.7 ± 0.1 1.1 ± 0.1 5.3 ± 0.2 0.27 19.5 ± 0.7 24.2 ± 0.7
FapC-PGG 190 ± 1 7.6 ± 0.2 1.7 ± 0.1 10.1 ± 0.2 0.31 27.2 ± 0.5 52.3 ± 0.5
FapC-EGCG 168 ± 1 6.7 ± 0.1 1.8 ± 0.1 7.2 ± 0.1 0.33 25.6 ± 0.3 32.4 ± 0.3
FapC-Baicalein 168 ± 1 6.7 ± 0.1 1.8 ± 0.1 10.0 ± 0.2 0.36 25.8 ± 0.4 48.1 ± 0.4
Notes: a Mw: Molecular weight determined by IFT. b Nagg: Number of monomers in the oligomer determined by
IFT. c Rg: The Rg of the chains that are flexible in the shell. d Rg: Determined with IFT for monomers and oligomers.
e f shell: Mass fraction of protein in the shell.
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Figure 8. Structural analysis of off-pathway oligomers purified by SEC. (A) TEM image of oligomers
show large spherical oligomers in the presence of inhibitors, in contrast to the small oligomers
formed in their absence. Scale bars are 200 nm; (B) far-ultra violet (UV) CD spectra of monomer and
SEC-purified oligomers both show largely random coil; (C) small-angle X-ray scattering (SAXS) data
(scattering intensity I (q) versus length of scattering vector (q)) for purified oligomers all show the same
overall shape; (D) pair distance distribution functions for the oligomers from panel c; (E) schematic
representation of a possible monomer arrangement in the oligomer.
The ∆R1R2R3 mutant lacking all three imperfect repeats also formed oligomers in the presence of
PGG, consistent with its behavior with EGCG (Figure 5D). SAXS analysis of this oligomer revealed
a similar core-shell structure as the other oligomers. Like the other oligomers, ~ one third of the protein
was found in the shell with flexible protein (f shell = 0.27), but the oligomer was considerably smaller
than that formed by full-length FapC, consisting of less than five monomers and a short axis diameter
of 19.5 ± 0.7 nm (Table 1).
For comparison, we also analyzed the freshly desalted samples of FapC, and the mutant ∆R1R2R3
both with and without TCEP. The SAXS data (Figure S10) are qualitatively different from those of the
oligomers, with a much less pronounced decay for increasing q. In the presence of TCEP, the IFT gave
aggregation numbers of 1.4 and 1.8 for FapC and ∆R1R2R3, respectively, whereas they were higher
without TCEP (4.4 and 2.7, respectively). The radii of gyration were 5.9 ± 0.1 nm for both proteins
with TCEP, and 10.1 ± 0.2 and 7.0 ± 0.1 nm without TCEP for FapC and ∆R1R2R3, respectively. The
data could be fitted well with the random coil model, which shows that the aggregates in the freshly
desalted samples are different from those of the purified oligomers, and do not have a compact core.
The model fitting gave similar results for aggregation numbers and radii of gyration.
3.6. The Polyphenols Reduce the Extent of Pseudomonas-UK4 Biofilm Formation
Finally, we analyzed the effect of inhibitors on biofilm formation of Pseudomonas fluorescens
UK4 which produces FapC-UK4. We have previously shown that the biofilm of this strain is
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strengthened mechanically by the production of amyloid [12]; unlike P. aeruginosa, amyloid formation
is not accompanied by alginate formation which can otherwise complicate biofilm quantification.
We incubated the fap overexpressing strain (pFap) in the presence of polyphenols, using either 96-well
peg-lid plates to quantify the extent of biofilm formation (staining by crystal violet) (Figure 9A) or
flow chambers for confocal microscopy images. We see a remarkably clear correlation between the
biofilm mass and ThT maximum emission (Figure 9B); the lower the emission (and thus the greater
the inhibition of aggregation), the lower the amount of biofilm formed. Confocal images (Figure 9C)
in the absence of polyphenols show that the pFap strain made more biofilm than wt and the ∆Fap
strain lacking the fap operon, where the bacteria show much less clumping. This emphasizes the
significant role of FapC amyloid in biofilm formation [16]. However, in the presence of PGG and
EGCG, the bacteria are more dispersed and there is a greater proportion of dead cells (which stain red
in Figure 9A).
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4. Discussion
A major challenge in the treatment of bacterial infections is the formation of a self-produced biofilm
matrix which protects the resident bacteria against conventional antibiotic, mechanical, and chemical
stresses. Several strategies have been used to develop therapeutic compounds to combat these biofilms.
Amyloid is known to strengthen this biofilm, as illustrated by the role of FapC in promoting biofilm in
Pseudomonas [16]. By inhibiting their formation, compounds such as polyphenols (many of which are
available in common dietary components) provide a potential tool in this combat. Hence, we have
carried out a study of the effect of five selected plant polyphenols on FapC fibrillation. Prior to that,
we established that smaller compounds such as gallic acid, catechin, epicatechin, and 3-hydroxytyrosol,
which represent subscaffolds of the larger polyphenols, performed poorly compared to the more
complex polyphenols. This indicates cooperativity effects from combining several functional groups
close in space.
A dose-response ThT-emission profile identified PGG (IC50~26 µM) as the best inhibitor, closely
followed by EGCG. Moreover, an increase in the nucleation time tN for both PGG and EGCG were
observed, also consistent with a depletion of monomer to a non-ThT-active phase. The aggregates that
accumulated in this process consisted of oligomers and larger non-fibrillar aggregates which were
not seen in the absence of these polyphenols. The oligomers were remarkably stable towards formic
acid, but did not seed fibrillation, consistent with their random coil structure and tendency to bind
polyphenols. Aggregates formed in the presence of inhibitors showed a slightly reduced ability to seed
compared to bona fide FapC fibrils, in particular aggregates with PGG, which also showed low β-sheet
content. The polyphenols’ effects are not limited to the prevention of fibrillation: We have previously
shown that EGCG can remodel FapC fibrils into non-amyloid aggregates [25].
4.1. EGCG Targets Hot Spots in FapC, Leading to Off-Pathway Unstructured Oligomers
Different truncation mutants of FapC lacking one or more of its imperfect were incubated with
polyphenols to address which parts are important in inhibition. A cocktail of different assays confirmed
R3 as the most important repeat whose deletion significantly extended the fibrillation lag phase,
followed by R2. PGG and EGCG consistently ranked as the two polyphenols with the greatest effect on
the mutants’ properties. The mutant ∆R1,2,3 lacking all three repeats underwent complete conversion
to oligomers, indicating that the linker region is also able to interact with EGCG. This is gratifyingly
consistent with our peptide array data which identifies “hot spots” for interaction with EGCG in
the linker region as well as repeats R2 and R3 which (unlike R1) contain the “GVNVAA” sequence,
previously identified as highly amyloidogenic in FapC-PAO1 [39]. The high hydrophobicity score of
this hexapeptide could provide a high potential for interaction of polyphenols in the EGCG. Thus, the
most amyloidogenic part and the linker region of monomer can interact with EGCG and significantly
inhibit the fibrillation process. Binding of a relatively large aromatic molecule such as PGG to FapC
monomers or early oligomers, confirmed by SEC and SDS-PAGE/NBT, may also sterically block
attachment of additional FapC monomers. The oligomers are formed within the first h of incubation,
preventing nucleation by the formation of a compact core surrounded by a flexible shell that consists
of ~ one third of the entire protein. The CD of separated off-pathway oligomers displayed random
coil structures such as the monomer, emphasizing that these species are not β-sheet and definitely
non-fibrillar. The polyphenol-stabilized oligomers are larger than the control oligomers formed in
the absence of polyphenols and are estimated to consist of ~7 monomers with short axis diameter
around 25–27 nm, significantly larger than the small oligomeric species formed in the absence of
polyphenols. In contrast, the polyphenol-free oligomers have a diameter estimated by TEM to be 10 ±
0.2 nm (cf. Figure 8A), which indicates that they contain a significantly lower number of monomers,
probably around 2–3.
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4.2. Biofilm may be Targeted through Their Amyloid Component
We also demonstrated a strong correlation between amyloid inhibition and the ability to reduce
biofilm formation in Pseudomonas sp.UK4, using a FapC overexpression strain, which showed high
levels of amyloid production and consequent biofilm formation in the absence of these polyphenols.
This biofilm reduction is likely to have direct consequences for the penetrance of antibiotics. Similarly,
treatment of P. aeroginosa biofilm by EGCG increased its susceptibility to antibiotics and decreased its
stiffness [25] (though high levels of alginate production complicated analysis of biofilm production in
this species), while the polyphenol tannic acid inhibits the ability of S. aureus to colonize surfaces [49].
While our polyphenols effectively inhibit biofilm formation in vivo, their chemical stability remains
an issue, given that the concentration of the original compound declines significantly over a 24-h
period. However, interactions with existing amyloid components (particularly chemical modifications)
occur within the first hour (as detected by our NBT assay). Given that fibrillation of our functional
proteins shows a lag time of several hours, there is clearly ample time for the polyphenols to interact
with their protein targets before fibrillation takes off in earnest. In practice, regular supplies of fresh
polyphenols (e.g., on a daily basis) would likely be sufficient to ensure full efficacy against unwanted
bacterial protein fibrillation. Furthermore, it should be noted that their chemical reactivity is connected
to their anti-oxidant potential, most likely through resonance stabilization of oxidation-induced free
radical states [50,51]. PGG scavenges reactive oxygen species such as superoxide (O2−) and H2O2,
enhancing resistance of neuronal cells to hydrogen peroxide [52,53]. Use of polyphenols against biofilm
is also encouraged by the observations that e.g., EGCG [54] and oleuropein [55] do not show toxicity
issues in animal models and EGCG has even progressed to clinical trials for use against Alzheimer’s
Disease [23].
In conclusion, our investigations suggest that phenol-rich compounds found plentifully in
fruits and plants have a substantial inhibitory effect on fibrillation of FapC, the major component of
amyloid structure in the biofilm of many different Pseudomonas strains. Further investigation of this
inhibitory effect revealed that strong interactions with the linker region and the most amyloidogenic
parts of the monomer led to off-pathway oligomers which do not propagate fibrils. We speculate
that R2, R3, and the C-terminal part of FapC may form the dense core of oligomer while the
flexible shell consists of R1 and the N-terminal region, though this will have to be substantiated
with e.g., hydrogen-deuterium exchange mass spectrometry [56]. These data highlight the role of
polyphenols, especially PGG, as promising compounds for controlling biofilm-related infections.
These findings may have repercussions for our understanding of how polyphenols affect fibrillation of
amyloidogenic proteins in neurodegenerative diseases.
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